Zilovertamab vedotin plus R-CHP versus R-CHOP for first-line treatment of diffuse large B-cell lymphoma: The phase 3 waveline-010 study

Authors

Anas Al-Janadi (ORCID: https://orcid.org/0000-0003-3531-6710)
Russell Gollard (ORCID: https://orcid.org/0000-0002-4959-7616)
Nishitha Reddy (ORCID: https://orcid.org/0000-0002-6059-9647)
Jessica Flynn (ORCID: https://orcid.org/0000-0001-8310-6684)
Rushdia Z. Yusuf

Controls

|||

ALL TIME

JAN

FEB

MAR

APR

MAY

JUN

JUL

AUG

SEP

OCT

article

Anas Al-Janadi, Russell Gollard, Nishitha Reddy, Jessica Flynn et al.

Nov 3, 2025

Blood

Lymphoma Diagnosis and Treatment

article

Anas Al-Janadi, Russell Gollard, Nishitha Reddy, Jessica Flynn, Rushdia Z. Yusuf

November 3, 2025article en

No abstract available for this paper.

BloodVol. 146(Supplement 1)

Grand Rapids Women's Health (US), Hawaii Cancer Care (US), China Railway Construction Corporation (China) (CN)

Openalex Percentile: Top 47%

Lymphoma Diagnosis and Treatment

AI Navigator

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.